SETD2 and pancreatic neoplasm: CTNNA1 inhibits tumor metastasis and cell growth through inhibition of EMT in bladder cancer, and the reversal of the oncogenic effect of EMT by miR-429 and Setd2 in colorectal and pancreatic cancers is also associated with CTNNA1.